USPH
USPH
U.S. Physical Therapy, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $202.73M ▲ | $19.86M ▲ | $-10.55M ▼ | -5.2% ▼ | $-0.44 ▼ | $21.94M ▼ |
| Q3-2025 | $164.02M ▼ | $11.54M ▼ | $7.24M ▼ | 4.42% ▼ | $0.48 ▼ | $31.11M ▼ |
| Q2-2025 | $164.18M ▲ | $16.69M ▲ | $8.81M ▼ | 5.37% ▼ | $0.58 ▼ | $31.13M ▲ |
| Q1-2025 | $152.55M ▼ | $11.42M ▼ | $9.9M ▲ | 6.49% ▲ | $0.8 ▲ | $25.47M ▼ |
| Q4-2024 | $180.45M | $19.16M | $7.44M | 4.12% | $0.52 | $26.06M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $35.57M ▲ | $1.2B ▲ | $433.81M ▲ | $476.43M ▼ |
| Q3-2025 | $31.1M ▼ | $1.2B ▲ | $413.83M ▼ | $503.57M ▲ |
| Q2-2025 | $34.09M ▼ | $1.18B ▼ | $414.01M ▼ | $500.75M ▲ |
| Q1-2025 | $39.18M ▼ | $1.18B ▲ | $420.68M ▲ | $497.26M ▲ |
| Q4-2024 | $41.36M | $1.17B | $408.42M | $488.93M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $5.61M ▼ | $24.93M ▲ | $-5.44M ▲ | $-15.02M ▼ | $4.47M ▲ | $21.01M ▲ |
| Q3-2025 | $17.64M ▼ | $19.94M ▼ | $-11.94M ▲ | $-10.99M ▲ | $-2.98M ▲ | $15.63M ▼ |
| Q2-2025 | $17.72M ▲ | $34.86M ▲ | $-12.71M ▼ | $-27.25M ▼ | $-5.1M ▼ | $31.61M ▲ |
| Q1-2025 | $9.9M ▼ | $-4.67M ▼ | $-6.63M ▲ | $9.12M ▲ | $-2.18M ▲ | $-7.25M ▼ |
| Q4-2024 | $12.49M | $19.41M | $-94.85M | $-153K | $-75.6M | $16.92M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Net Patient Revenues | $150.00M ▲ | $160.00M ▲ | $160.00M ▲ | $170.00M ▲ |
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at U.S. Physical Therapy, Inc.'s financial evolution and strategic trajectory over the past five years.
USPH combines a profitable core business with solid cash generation, moderate leverage, and adequate liquidity. It has a differentiated partnership model that keeps local leaders invested, a growing industrial injury prevention segment, expanding home-care capabilities, and emerging technology tools that improve efficiency. The national scale in a fragmented industry, plus alliances with hospitals and large employers, further reinforce its position. Overall, the financials and business model suggest a resilient, well-established platform.
Key risks include heavy reliance on goodwill and intangible assets from acquisitions, which could be vulnerable if acquired practices underperform. The company operates with moderate debt and has been returning significant cash to shareholders, which reduces room for error if operating trends weaken. Industry-specific risks—reimbursement cuts, regulatory change, therapist supply constraints, and wage pressures—are ongoing concerns. The strategy also depends on successful integration of acquisitions, rollout of new clinics and technologies, and continued demand from employer clients for injury-prevention services.
The outlook appears cautiously constructive. USPH has the ingredients for continued growth: a scalable partnership model, strong cash flow, room for additional acquisitions, and multiple growth vectors in industrial injury prevention, home-based care, and new clinics. At the same time, future performance will hinge on maintaining margin discipline, navigating reimbursement and labor headwinds, and ensuring that its innovation and technology efforts translate into real operational gains. With only one year of detailed data, long-term trends are not yet visible, so ongoing monitoring of growth, profitability, and balance-sheet quality is important to understand how the story evolves.
About U.S. Physical Therapy, Inc.
https://www.usph.comU.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $202.73M ▲ | $19.86M ▲ | $-10.55M ▼ | -5.2% ▼ | $-0.44 ▼ | $21.94M ▼ |
| Q3-2025 | $164.02M ▼ | $11.54M ▼ | $7.24M ▼ | 4.42% ▼ | $0.48 ▼ | $31.11M ▼ |
| Q2-2025 | $164.18M ▲ | $16.69M ▲ | $8.81M ▼ | 5.37% ▼ | $0.58 ▼ | $31.13M ▲ |
| Q1-2025 | $152.55M ▼ | $11.42M ▼ | $9.9M ▲ | 6.49% ▲ | $0.8 ▲ | $25.47M ▼ |
| Q4-2024 | $180.45M | $19.16M | $7.44M | 4.12% | $0.52 | $26.06M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $35.57M ▲ | $1.2B ▲ | $433.81M ▲ | $476.43M ▼ |
| Q3-2025 | $31.1M ▼ | $1.2B ▲ | $413.83M ▼ | $503.57M ▲ |
| Q2-2025 | $34.09M ▼ | $1.18B ▼ | $414.01M ▼ | $500.75M ▲ |
| Q1-2025 | $39.18M ▼ | $1.18B ▲ | $420.68M ▲ | $497.26M ▲ |
| Q4-2024 | $41.36M | $1.17B | $408.42M | $488.93M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $5.61M ▼ | $24.93M ▲ | $-5.44M ▲ | $-15.02M ▼ | $4.47M ▲ | $21.01M ▲ |
| Q3-2025 | $17.64M ▼ | $19.94M ▼ | $-11.94M ▲ | $-10.99M ▲ | $-2.98M ▲ | $15.63M ▼ |
| Q2-2025 | $17.72M ▲ | $34.86M ▲ | $-12.71M ▼ | $-27.25M ▼ | $-5.1M ▼ | $31.61M ▲ |
| Q1-2025 | $9.9M ▼ | $-4.67M ▼ | $-6.63M ▲ | $9.12M ▲ | $-2.18M ▲ | $-7.25M ▼ |
| Q4-2024 | $12.49M | $19.41M | $-94.85M | $-153K | $-75.6M | $16.92M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Net Patient Revenues | $150.00M ▲ | $160.00M ▲ | $160.00M ▲ | $170.00M ▲ |
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at U.S. Physical Therapy, Inc.'s financial evolution and strategic trajectory over the past five years.
USPH combines a profitable core business with solid cash generation, moderate leverage, and adequate liquidity. It has a differentiated partnership model that keeps local leaders invested, a growing industrial injury prevention segment, expanding home-care capabilities, and emerging technology tools that improve efficiency. The national scale in a fragmented industry, plus alliances with hospitals and large employers, further reinforce its position. Overall, the financials and business model suggest a resilient, well-established platform.
Key risks include heavy reliance on goodwill and intangible assets from acquisitions, which could be vulnerable if acquired practices underperform. The company operates with moderate debt and has been returning significant cash to shareholders, which reduces room for error if operating trends weaken. Industry-specific risks—reimbursement cuts, regulatory change, therapist supply constraints, and wage pressures—are ongoing concerns. The strategy also depends on successful integration of acquisitions, rollout of new clinics and technologies, and continued demand from employer clients for injury-prevention services.
The outlook appears cautiously constructive. USPH has the ingredients for continued growth: a scalable partnership model, strong cash flow, room for additional acquisitions, and multiple growth vectors in industrial injury prevention, home-based care, and new clinics. At the same time, future performance will hinge on maintaining margin discipline, navigating reimbursement and labor headwinds, and ensuring that its innovation and technology efforts translate into real operational gains. With only one year of detailed data, long-term trends are not yet visible, so ongoing monitoring of growth, profitability, and balance-sheet quality is important to understand how the story evolves.

CEO
Christopher J. Reading
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2001-06-29 | Forward | 3:2 |
| 2001-01-08 | Forward | 2:1 |
ETFs Holding This Stock
IJR
Weight:0.08%
Shares:924.21K
XSMC.TO
Weight:0.08%
Shares:924.21K
VTS.AX
Weight:0.00%
Shares:477.39K
Summary
Showing Top 3 of 146
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:2.29M
Value:$190.23M
BLACKROCK, INC.
Shares:2.2M
Value:$182.51M
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Shares:1.35M
Value:$112.27M
Summary
Showing Top 3 of 327

